UPDATE 2-Allergan revenue disappoints as Alzheimer drug loses exclusivity
 

UPDATE 2-Allergan revenue disappoints as Alzheimer drug loses exclusivity

Aug 8 (Reuters) – Allergan Plc reported
weaker-than-expected quarterly revenue after sales of its
Alzheimer’s drug, Namenda IR, collapsed following the loss of
patent exclusivity, and the company cut…http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...9c:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...9c:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/4bI4OwojQ-A